Abstract Introduction: The objective of this systematic review is to investigate the effectiveness, efficacy and safety of multiple concomitant lifestyle modification therapies for patients with hypertension or prehypertension. Methods and analysis: Electronic searches will be performed in the Cochrane Library, OVID, EMBASE etc., along with manual searches in the reference lists of relevant papers found during electronic search. We will identify eligible randomized controlled trials utilizing multiple lifestyle modification to lower blood pressure. The control could be drug therapy, single lifestyle change or no intervention. Changes in SBP and DBP constitute primary endpoints, and secondary endpoints include the number of patients meeting office target blood pressure; number of patients reporting microvascular or macrovascular complications etc. We will extract descriptive, methodological and efficacy data from identified RCTs. We will calculate the Relative risk for proportion of patients with a normal blood pressure in experimental group. Dichotomous data will be analysed using risk difference and continuous data using weighted mean differences, both with 95% CI. We will use both the Chi-squared test and the I-squared statistic to assess heterogeneity. We will use fixed effects model to compute the efficacy unless there was evidence of heterogeneity. If heterogeneity of effect size persisted with respect to blood pressure change, further meta-regression was performed within groups. We will examine the potential for publication bias by using a funnel plot. Dissemination: we will synthesize results from RCTs which provides more precise and accurate information on the effect of multiple lifestyle changes on blood pressure. The results of this review will increase understanding of multiple lifestyle modification for patients with hypertension or prehypertension. Keywords: multiple lifestyle modification; hypertension; prehypertension; systematic review. Trail registration: Our protocol is registered on PROSPERO (CRD42013006476), http://www.crd.your.ac.uk/PROSPERO.
Strengths and limitations of this study
To our knowledge, this is the first systematic review to investigate the effectiveness, efficacy and safety of multiple lifestyle changes for patients with hypertension. The results of this systematic review can provide clinicians useful clinical information to guide their patient care and increase understanding of lifestyle modification, motivate patients with hypertension to adopt and maintain multiple lifestyle changes. The limitation of this systematic review may be difficult in retrieving all the multiple lifestyle modification for patients with hypertension. We will cooperated with experienced medical librarian to design search strategy, in order to make sure a broad search.
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For peer review only -http://bmjopen.bmj.com/site/about/guidelines.xhtml 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  p  e  e  r  r  e  v  i  e  w  o  n  l  y Background Essential hypertension continues to be an important public-health challenge worldwide [1] . Hypertension(7%) is the leading cause of death followed by stroke(16.6%), heart failure(7.3%) [2] . Hypertension is an independent risk factor affecting the development of cardiovascular disease(myocardial infarction, heart failure and stroke), chronic kidney disease and peripheral vascular disease [2] . Hypertension affects 29.3 % of the adult population in the United States [3] . Which affects almost 18.8% among Chinese population according to the fourth National Nutrition and Health Survey in 2002 [4] . The JNC-7 created a new category of hypertension, "prehypertension" [5] which is defined as SBP of 120-139 mmHg or DBP of 80-89 mmHg. Patients in this category are at increased risk for progression to hypertension. Numerous studies emerged afterward to investigate the risk of prehypertension for various types of adverse outcomes, including stroke, coronary heart disease, and CVD and all-cause mortality [6] [7] [8] [9] . From 2005 to 2006, approximately three of eight adults in the United States had BP in the prehypertensive range of 120-139/80-89 mmHg and roughly one in eight adults had BP in the range of 130-139/85-89 mmHg [10] . Furthermore, the number of hypertensive and prehypertensive patients is still increasing. Although hypertension and prehypertension affects a large portion of the population, recognition and adequate treatment are less than ideal [11] . Despite the availability of multiple effective antihypertensive drugs, hypertension control rates remain poor. And hypertension expenditures represent a significant amount of health care resource use [12] . The total annual medical expenditures attributed to hypertension including co-morbidities are estimate to range from ﹩108-110 billion dollars [13] . As we known, many antihypertensive treatments cause side effects such as dizziness, headache, fatigue, chest discomfort, cough, and sexual dysfunction, prompting some patients to discontinue therapy. Therefore, there is an urgent need to develop and implement non-pharmacological methods (such as salt reduction, weight loss, and exercise) to improve prevention and treatment of this major cause of death. As a modifiable risk factor, Treatment of prehypertension and hypertension through lifestyle changes is a vital approach [14] . And lifestyle interventions have a profound impact on the national economic impact of hypertension [12] . The JNC-8 [15] and 2013 ESH/ESC [16] guidelines and the results of trails [17] [18] [19] [20] on lifestyle modification for hypertension recommended that lifestyle modification is capable to lower the blood pressure. However, little is known about the efficacy of programs that intervene on multiple lifestyle factors to maximize blood pressure lowering effect. And evidence regarding the magnitude of multiple lifestyle modification-related reductions in blood pressure is inconsistent. And the benefits of multiple lifestyle changes have not been carefully examined. We raised the following questions: (1) Is multiple concomitant lifestyle modification therapy effective for patients with hypertension or prehypertension? (2) If so, what is the magnitude of multiple lifestyle modification-related reductions on blood pressure? We will pool results from randomized control trials provides more precise and accurate information on the effect of multiple lifestyle changes on blood pressure. Criteria for considering studies for this review Type of studies The review will include randomized controlled trials published in English language only. Completed or ongoing trials will be included in this review, as well as trials using parallel design only.
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Participant characteristics
Participant to be included are adult participants ( ≥ 18 years of age) presenting with pre-hypertension (systolic blood pressure: 120～139 mmHg; diastolic blood pressure 80～ 89mmHg) or essential hypertension (systolic blood pressure≥140mmHg; diastolic blood pressure≥90mmHg) according to JNC guideline [5] . Restrictions will not be placed on gender or ethnic background of participants.
Intervention characteristics
Studies utilizing multiple lifestyle modification (a combination of at least two of the following methods: weight loss [21] , DASH diet [22] [23] [24] [25] , dietary sodium reduction [26] , physical activity [27] , moderation of alcohol consumption) will be reviewed. We include multiple lifestyle modification consisted of at least dietary pattern changes (including sodium reduction) and physical activity. We also allow co-intervention if they were applied in all arms (including antihypertensive drugs, self-monitoring). The lifestyle modification should last for at least 4 weeks, and the follow up phase should be at least 4 weeks. And how did the patients implement the lifestyle changing must be specified in the original article. However, studies using nurse, physician or pharmacologist counseling (face to face, group counseling etc.), computer or telephone monitoring will be excluded. 
Control arm characteristics
Outcome measures
The primary outcomes of this systematic review are the changes of SBP and DBP between baseline and after treatment. The secondary outcomes including (1) the number of patients meeting office target blood pressure; (2) number of patients reporting microvascular complications (retinopathy, neuropathy, nephropathy); (3) the number of patients with macrovascular complications (cardiovascular disease, stroke/transient ischemic attack, myocardial infarction, peripheral vascular disease); (4) number of patients who were reported all-cause mortality(eg. cardiovascular mortality ) The whole process of this systematic review is presented in figure 1.
Database and Search
We will identify relevant randomized controlled trials, only in English language, by a systematic search of EMBASE, MEDLINE, AMED, Cochrane library, CINAHL, ISI web of knowledge and the Cochrane Central Registry of Controlled Trials. An experienced medical librarian design terms (see table 1 ) to retrieve trials enrolling participants with pre-hypertension or hypertension managed with multiple lifestyle modification. Reviewers will scan all the retrieved trials and other relevant articles. The reference of the articles reported trials meeting our inclusion criteria will be hand searched for possible candidate trials. We also searched for ongoing trials from mainstream registries, such as the metaRegister of Controlled Trials, ClinicalTrials. gov trials registry, the Australian New Zealand Clinical Trials Registry etc.
Studies selection
Two experienced reviewers (JL and JC) will independently screen the titles and abstracts of identified citations for potential eligible trials and exclude the duplicates. Then they will apply eligibility criteria to the full text of potentially eligible trials. If the reviewers (HZ and JL) can not clearly screen the trials according to titles and abstracts, the other two reviewers (JC and CL) will screen the full copies of these studies. Conflicts will be resolved by team discussion. If the disagreement persisted, a third reviewer (FRL) will be consulted.
Data extraction
Data were extracted independently using a standardized extraction form by two reviewers (HZ and JL) concerning patient characteristics(age, gender, BMI, etc.), study characteristics (interventions, control arms, length of intervention, length of follow-up and so on), type of blood pressure monitoring (office, home, ambulatory), co-intervention and outcome(SBP, DBP, cardiovascular events, etc.). If data were missing from published reports, we will contact the authors of the included trials for further information. Disagreements will be resolved by team discussion. FRL will review the data to ensure no input data errors.
Risk of bias assessment
Two reviewers will assess the risk of bias independently using the Cochrane of risk of bias tool. The following items will be assessed (www.cochrane-handbook.org.): Random sequence generation (selection bias); Allocation concealment (selection bias); Blinding (performance bias and detection bias); Incomplete outcome data (attrition bias); Selective outcome reporting (reporting bias). The risk of bias is categorized as low/unclear/high risk of bias. Trials which meet all criteria will be judged as having a low risk of bias, trials which meet none of the criteria will be judged as having a high risk of bias, and trials with insufficient information to judge will be classified as unclear risk of bias. Disagreement between the reviewers over the risk of bias in specific studies will be resolved by discussion and consensus, with involvement of a third review author (FRL)where necessary.
Strategy for data synthesis
Weight mean differences (WMD) will be calculated for the overall mean change from baseline of both systolic and diastolic blood pressure (using office, casual or ambulatory blood pressure measurements) for experimental and control groups. When proportion of responders (participants who reported a BP lower than 140/90mmHg after treatment) was reported, we will calculate the relative risk (RR), using control group as a reference. We will assess heterogeneity using the Higgins I 2 statistics, an I 2 >25% will be considered as existing heterogeneity among studies. In that case, we will firstly use meta-regression to find out the source of heterogeneity (age, gender, interventions, outcome measurements, etc.), and then use subgroup analysis. If the problem remains, we will use random effect model and explain the results with caution. Fixed effect model will be used when there is no evidence of heterogeneity. We will examine the potential for publication bias by using a funnel plot. If the data is not appropriate to perform a meta-analysis, we will just do a narrative synthesis. Analyses will be performed with R project 3.02 (http://www.r-project.org). If required data were not reported, we will request data from corresponding author. However, if the missing data are out of reach, we will exclude such studies, synthesis the data from the rest of the included studies.
Analysis of subgroups or subset
To investigate potential heterogeneity across studies, we will conduct subgroup analysis based on different combination of lifestyles, classification of blood pressure（prehypertension, mild hypertension, moderate hypertension, severe hypertension）, quality of evidence. Random effects meta-regression models will be used to quantify the difference between subgroups and test for statistical significant interactions among subgroups.
Sensitivity analysis
We will conduct sensitivity analysis to assess the effects of individual studies on the combined estimates and determine whether certain studies dominate the pooled event (particularly, if these studies were at high risk of bias). If certain studies have borderline eligibility status for any reason, analysis will be conducted with and without such studies.
Discussion Many existing systematic reviews [26 27 ] focus on the effect of single lifestyle modification on blood pressure. Although single lifestyle modification has been shown to lower elevated blood pressure, it is currently not known whether their combined use produces an additive antihypertensive effect. Of the various lifestyle interventions, physical activity and dietary intervention have been shown to diminish the blood pressure and reduce CVD events, which have emerged as the 2 most effective and physiologically desirable approaches. That is There is no systematic review have attempted to investigate the effectiveness of multiple lifestyle changes simultaneously. The aim of this systematic review is to synthesize available evidence of effectiveness of multiple lifestyle intervention in the treatment of prehypertension and hypertension. The systematic review also intends to help clinician to make decision on the clinical applicability of the multiple lifestyle modification; at the same time, the results of this review will increase understanding of multiple lifestyle change for patients with prehypertension and hypertension; encourage and motivate the patients with prehypertension or hypertension to adopt and maintain mulitple lifestyle changes in their daily home life so as to improve hypertension outcomes. However, we will select the trials which implemented the multiple lifestyle intervention for at least 4 weeks. The multiple lifestyle intervention has to sustain for a time to achieve the effect to lower the blood pressure. And the trials employ lifestyle modification therapy usually intervene for more than four weeks [20 28 29] . The reason why we exclude the trials utilizing counseling or monitoring is that both of them had been reported to achieve antihypertensive effect [30] [31] [32] . No matter counseling or monitoring, lots of manpower, material resources and financial resources have to be invested. Moreover, we exclude such trials so as to investigate the genuine effect of the multiple lifestyle modification. This systematic review will provide a general view and evidence of effect of multiple lifestyle change on blood pressure. The informations of this systematic review will also provide clinicians useful implication to guide their patient care. The finding of the systematic review will be disseminated through publication in a peer reviewed journal, reporting of the systematic review will follow recommendations described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [34]statement and the Cochrane Handbook for Intervention Reviews [35] , and will be formatted according to specific journal publication guideline. 
Abstract
Introduction: The objective of this systematic review is to investigate the effectiveness, efficacy and safety of multiple concomitant lifestyle modification therapies for patients with hypertension or prehypertension. Methods and analysis: Electronic searches will be performed in the Cochrane Library, OVID, EMBASE etc., along with manual searches in the reference lists of relevant papers found during electronic search. We will identify eligible randomized controlled trials utilizing multiple lifestyle modification to lower blood pressure. The control could be drug therapy, single lifestyle change or no intervention. Changes in SBP and DBP constitute primary endpoints, and secondary endpoints include the number of patients meeting office target blood pressure; number of patients reporting microvascular or macrovascular complications etc. We will extract descriptive, methodological and efficacy data from identified RCTs. We will calculate the Relative risk for proportion of patients with a normal blood pressure in experimental group. Dichotomous data will be analysed using risk difference and continuous data using weighted mean differences, both with 95% CI. We will use both the Chi-squared test and the I-squared statistic to assess heterogeneity. We will use fixed effects model to compute the efficacy unless there was evidence of heterogeneity. If heterogeneity of effect size persisted with respect to blood pressure change, further meta-regression was performed within groups. We will examine the potential for publication bias by using a funnel plot. Dissemination: We will synthesize results from RCTs which provides more precise and accurate information on the effect of multiple lifestyle changes on blood pressure. The results of this review will increase understanding of multiple lifestyle modification for patients with hypertension or prehypertension. Keywords: multiple lifestyle modification; hypertension; prehypertension; systematic review. Trail registration: Our protocol is registered on PROSPERO (CRD42013006476), http://www.crd.your.ac.uk/PROSPERO.
Background
Essential hypertension continues to be an important public-health challenge worldwide[1]. Hypertension(7%) is the leading cause of death followed by stroke(16.6%), heart failure(7.3%) [2] . Hypertension is an independent risk factor affecting the development of cardiovascular disease(myocardial infarction, heart failure and stroke), chronic kidney disease and peripheral vascular disease [2] . Hypertension affects 29.3 % of the adult population in the United States [3] . Which affects almost 18.8% among Chinese population according to the fourth National Nutrition and Health Survey in 2002 [4] . The JNC-7 created a new category of hypertension, "prehypertension" [5] which is defined as SBP of 120-139 mmHg or DBP of 80-89 mmHg. Patients in this category are at increased risk for progression to hypertension. Numerous studies emerged afterward to investigate the risk of prehypertension for various types of adverse outcomes, including stroke, coronary heart disease, and CVD and all-cause mortality [6] [7] [8] [9] . [10] . Furthermore, the number of hypertensive and prehypertensive patients is still increasing. Although hypertension and prehypertension affects a large portion of the population, recognition and adequate treatment are less than ideal [11] . Despite the availability of multiple effective antihypertensive drugs, hypertension control rates remain poor. And hypertension expenditures represent a significant amount of health care resource use [12] . The total annual medical expenditures attributed to hypertension including co-morbidities are estimate to range from ﹩108-110 billion dollars [13] . As we known, many antihypertensive treatments cause side effects such as dizziness, headache, fatigue, chest discomfort, cough, and sexual dysfunction, prompting some patients to discontinue therapy. Therefore, there is an urgent need to develop and implement non-pharmacological methods (such as salt reduction, weight loss, and exercise) to improve prevention and treatment of this major cause of death. As a modifiable risk factor, Treatment of prehypertension and hypertension through lifestyle changes is a vital approach [14] . And lifestyle interventions have a profound impact on the national economic impact of hypertension [12] . The JNC-8 [15] and 2013 ESH/ESC [16] guidelines and the results of trails [17] [18] [19] [20] on lifestyle modification for hypertension recommended that lifestyle modification is capable to lower the blood pressure. However, little is known about the efficacy of programs that intervene on multiple lifestyle factors to maximize blood pressure lowering effect. And evidence regarding the magnitude of multiple lifestyle modification-related reductions in blood pressure is inconsistent. And the benefits of multiple lifestyle changes have not been carefully examined. We raised the following questions: (1) Is multiple concomitant lifestyle modification therapy effective for patients with hypertension or 
Method and design Protocol and registration
Our protocol is registered on PROSPERO (CRD42013006476), http://www.crd.your.ac.uk/PROSPERO.
Criteria for considering studies for this review Type of studies
The review will include randomized controlled trials published in English language only. Completed or ongoing trials will be included in this review, as well as trials using parallel design only.
Participant characteristics
Intervention characteristics
Studies utilizing multiple lifestyle modification (a combination of at least two of the following methods: weight loss [21] , DASH diet [22] [23] [24] [25] , dietary sodium reduction [26] , physical activity [27] , moderation of alcohol consumption) will be reviewed. We include multiple lifestyle modification consisted of at least dietary pattern changes (including sodium reduction) and physical activity. We also allow co-intervention if they were applied in all arms (including antihypertensive drugs, self-monitoring). The lifestyle modification should last for at least 4 weeks, and the follow up phase should be at least 4 weeks. And how did the patients implement the lifestyle changing must be specified in the original article. However, studies using nurse, physician or pharmacologist counseling (face to face, group counseling etc.), computer or telephone monitoring will be excluded.
Control arm characteristics
Studies utilizing any type of non-pharmacological treatment, single lifestyle change, waiting list， no intervention or any type of antihypertensive drugs as a control arms will be included. We will include the following controls: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Database and Search
We will identify relevant randomized controlled trials, only in English language, by a systematic search of EMBASE, MEDLINE, AMED, Cochrane library, CINAHL, ISI web of knowledge and the Cochrane Central Registry of Controlled Trials. An experienced medical librarian design terms (see table 1) to retrieve trials enrolling participants with pre-hypertension or hypertension managed with multiple lifestyle modification. Reviewers will scan all the retrieved trials and other relevant articles. The reference of the articles reported trials meeting our inclusion criteria will be hand searched for possible candidate trials. We also searched for ongoing trials from mainstream registries, such as the metaRegister of Controlled Trials, ClinicalTrials. gov trials registry, the Australian New Zealand Clinical Trials Registry etc.
Studies selection
Data extraction
Risk of bias assessment
Strategy for data synthesis
Weight mean differences (WMD) will be calculated for the overall mean change from baseline of both systolic and diastolic blood pressure (using office, casual or ambulatory blood pressure measurements) for experimental and control groups. When proportion of responders (participants who reported a BP lower than 140/90mmHg after treatment) was reported, we will F o r p e e r r e v i e w o n l y calculate the relative risk (RR), using control group as a reference. We will assess heterogeneity using the Higgins I 2 statistics, an I 2 >25% will be considered as existing heterogeneity among studies. In that case, we will firstly use meta-regression to find out the source of heterogeneity (age, gender, interventions, outcome measurements, etc.), and then use subgroup analysis. If the problem remains, we will use random effect model and explain the results with caution. Fixed effect model will be used when there is no evidence of heterogeneity. We will examine the potential for publication bias by using a funnel plot. If the data is not appropriate to perform a meta-analysis, we will just do a narrative synthesis. Analyses will be performed with R project 3.02 (http://www.r-project.org). If required data were not reported, we will request data from corresponding author. However, if the missing data are out of reach, we will exclude such studies, synthesis the data from the rest of the included studies.
Analysis of subgroups or subset
Sensitivity analysis
Discussion Many existing systematic reviews [26 27 ] focus on the effect of single lifestyle modification on blood pressure. Although single lifestyle modification has been shown to lower elevated blood pressure, it is currently not known whether their combined use produces an additive antihypertensive effect. Of the various lifestyle interventions, physical activity and dietary intervention have been shown to diminish the blood pressure and reduce CVD events, which have emerged as the 2 most effective and physiologically desirable approaches. That is why we defined that the multiple lifestyle changes should at least including physical activity and dietary intervention. There is no systematic review have attempted to investigate the effectiveness of multiple lifestyle changes simultaneously. The aim of this systematic review is to synthesize available evidence of effectiveness of multiple lifestyle intervention in the treatment of prehypertension and hypertension. The systematic review also intends to help clinician to make decision on the clinical applicability of the multiple lifestyle modification; at the same time, the results of this review will increase understanding of multiple lifestyle change for patients with prehypertension and hypertension; encourage and motivate the patients with prehypertension or hypertension to adopt and maintain mulitple lifestyle changes in their daily home life so as to improve hypertension outcomes. However, we will select the trials which implemented the multiple lifestyle intervention for at least 4 weeks. The multiple lifestyle intervention has to sustain for a time to achieve the effect to lower the blood pressure. And the trials employ lifestyle modification therapy usually intervene for more than four weeks [20 28 29] .
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Strengths and limitations of this study
To our knowledge, this is the first systematic review to investigate the effectiveness, efficacy and safety of multiple lifestyle changes for patients with hypertension. The results of this systematic review can provide clinicians useful clinical information to guide their patient care and increase understanding of lifestyle modification, motivate patients with hypertension to adopt and maintain multiple lifestyle changes. The limitation of this systematic review may be difficult in retrieving all the multiple lifestyle modification for patients with hypertension. We will cooperated with experienced medical librarian to design search strategy, in order to make sure a broad search. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 of patients who were reported all-cause mortality Two reviewers will independently determine RCT eligibility. Disagreement will be solved by a third reviewer. We will extract descriptive, methodological and efficacy data in duplicate. We will use the Cochrane of risk of bias tool to assess the risk of bias. We will calculate the Relative risk (RR) for proportion of patients with a normal blood pressure in experimental group. Dichotomous data will be analysed using risk difference and continuous data using weighted mean differences, both with 95% CI. We will use both the Chi-squared test and the I-squared statistic to assess heterogeneity. We will use fixed effects model to compute the efficacy unless there was evidence of heterogeneity. If heterogeneity of effect size persisted with respect to blood pressure change, further meta-regression was performed within groups. We will examine the potential for publication bias by using a funnel plot. If the data is not appropriate to perform a meta-analysis, we will just do a narrative synthesis. Ethics and disseminationDissemination: we will synthesize results from RCTs which provides more precise and accurate information on the effect of multiple lifestyle changes on blood pressure. The results of this review will increase understanding of multiple lifestyle modification for patients with hypertension or prehypertension.this systematic review aims to synthesize results from randomized control trials provides more precise and accurate information on the effect of comprehensive lifestyle change on blood pressure. The results of this review will increase understanding of comprehensive lifestyle modification for patients with hypertension or prehypertension. Keywords: comprehensivemultiple lifestyle modification; hypertension; meta-analysis; systematic review. Trail registration: Our protocol is registered on PROSPERO (CRD42013006476), http://www.crd.your.ac.uk/PROSPERO. Background Essential hypertension continues to be an important public-health challenge worldwide[1]. Hypertension(7%) is the leading cause of death followed by stroke(16.6%), heart failure(7.3%) [2] . Hypertension is an independent risk factor affecting the development of cardiovascular disease(myocardial infarction, heart failure and stroke), chronic kidney disease and peripheral vascular disease [2] . Hypertension affects 29.3 % of the adult population in the United States [3] . Which affects almost 18.8% among Chinese population according to the fourth National Nutrition and Health Survey in 2002 [4] . The seventh report of the JNC created a new category of hypertension, "prehypertension" which is defined as SBP OF 120-139 mmHg or DBP of 80-89 mmHg. Patients in this category are at increased risk for progression to hypertension. Numerous studies emerged afterward to investigate the risk of prehypertension for various types of adverse outcomes, including stroke, coronary heart disease, and CVD and all-cause mortality [5] [6] [7] [8] . Based on the third National Health and Nutrition Examination Survey (NHANES III; 1999-2000) the prevalence of PHT among adults in the United States was 31% [9] . In the Women's Health Initiative Report, prevalence by race-ethnic groups was provided and ranged from 32-40% [10] . in this category are at increased risk for progression to hypertension. Numerous studies emerged afterward to investigate the risk of prehypertension for various types of adverse outcomes, including stroke, coronary heart disease, and CVD and all-cause mortality [6] [7] [8] [9] . From 2005 to 2006, approximately three of eight adults in the United States had BP in the prehypertensive range of 120-139/80-89 mmHg and roughly one in eight adults had BP in the range of 130-139/85-89 mmHg [10] . Furthermore, the number of hypertensive and prehypertensive patients is still increasing. Although hypertension affects a large portion of the population, recognition and adequate treatment are less than ideal. Despite the availability of comprehensivemultiple effective antihypertensive drugs, hypertension control rates remain poor [11] . And hypertension expenditures represent a significant amount of health care resource use [12] . The total annual medical expenditures attributed to hypertension including co-morbidities are estimate to range from ﹩108-110 billion dollars [13] . As we known, many antihypertensive treatments cause side effects such as dizziness, headache, fatigue, chest discomfort, cough, and sexual dysfunction, prompting some patients to discontinue therapy. Therefore, there is an urgent need to develop and implement non-pharmacological methods (such as salt reduction, weight loss, and exercise) to improve prevention and treatment of this major cause of death. As a modifiable risk factor, Treatment of prehypertension and hypertension through lifestyle changes is a vital approach [14] .And lifestyle interventions have a profound impact on the national economic impact of hypertension [12] . The JNC-7 [15] and ESH/ESC [16 17] guidelines and the results of trails [18] [19] [20] [21] on lifestyle modification for hypertension recommended that lifestyle modification is capable to lower the blood pressure. However, little is known about the efficacy of programs that intervene on comprehensive lifestyle factors to maximize blood pressure lowering effect. And evidence regarding the magnitude of comprehensive lifestyle modification-related reductions in blood pressure is inconsistent. And the benefits of comprehensivemultiple lifestyle have not been carefully examined. We raised the following questions: (1) Is multiple concomitant lifestyle modification therapy effective for patients with hypertension or prehypertension? (2) If so, what is the magnitude of multiple lifestyle modification-related reductions on blood pressure? We will pool results from randomized control trials provides more precise and accurate information on the effect of multiple lifestyle changes on blood pressure.Our aim is to determine whether comprehensive lifestyle modification is an attractive and appropriate first step treatment for hypertension. We will pool results from randomized control trials provides more precise and accurate information on the effect of comprehensive lifestyle change on blood pressure.
Method and design Protocol and registration
Our protocol is registered on PROSPERO (CRD42013006476), http://www.crd.your.ac.uk/PROSPERO. Criteria for considering studies for this review Type of studies The review will include randomized controlled trials published in English language only. Completed or ongoing trials will be included in this review, as well as trials using parallel design only. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r p e e r r e v i e w o n l y pre-hypertension (systolic blood pressure: 120～139 mmHg; diastolic blood pressure 80～ 89mmHg) or essential hypertension (systolic blood pressure≥140mmHg; diastolic blood pressure≥90mmHg) according to JNC guideline [15] . Restrictions will not be placed on gender or ethnic background of participants.
Participant characteristics
Intervention characteristics
Studies utilizing comprehensivemultiple lifestyle modification (a combination of at least two of the following methods: weight loss [22] , DASH diet [23] [24] [25] [26] , dietary sodium reduction [27] , physical activity [28] , moderation of alcohol consumption) will be reviewed. We include comprehensivemultiple lifestyle modification consisted of at least dietary pattern changes (including sodium reduction) and physical activity We also allow co-intervention if they were applied in all arms (including antihypertensive drugs, self-monitoring). The lifestyle modification should last for at least 4 weeks, and the follow up phase should be at least 4 weeks. And how did the patients implement the lifestyle changing must be specified in the original article. However, studies using nurse, physician or pharmacologist counseling (face to face, group counseling etc.), computer or telephone monitoring will be excluded.
Control arm characteristics
Studies utilizing any type of non-pharmacological treatment, single lifestyle change, no intervention or any type of antihypertensive drugs as a control arms will be included. We consider to include the following controls: 
Outcome measures
Database and Search
We will identify relevant randomized controlled trials, only in English language, by a systematic searchof EMBASE, MEDLINE, AMED, Cochrane library, CINAHL, ISI web of knowledge and the Cochrane Central Registry of Controlled Trials. An experienced medical librarian design terms (see appendix file 1) to retrieve trials enrolling participants with pre-hypertension or hypertension managed with comprehensivemultiple lifestyle modification. Reviewer will scan all the retrieved trials and other relevant articles. The reference of the articles reported trials meeting our inclusion criteriawill be hand searched for possible candidate trials. We also searched for ongoing trials from mainstream registries: the metaRegister of Controlled Trials, ClinicalTrials. gov trials registry, the Australian New Zealand Clinical Trials Registry. The 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Studies selection
Two experienced reviewers (JL and JC) will independently screen the titles and abstracts of identified citations for potential eligible trials and exclude the duplicates. Then they will apply eligibility criteria to the full text of potentially eligible trials. If the reviewers (HZ and JL) can not clearly screen the trials according to titles and abstracts, the other two reviewers (JC and CL) will screen the full copies of these studies. Conflicts will be resolved by team discussion. If the disagreement persisted, a third reviewer (FRL) will be consulted. Two experienced reviewers (JL and JC) will independently screen the titles and abstracts of identified citations for potential eligible trials and exclude the duplicates. Then they will apply eligibility criteria to the full text of potentially eligible trials. Conflicts will be resolved by team discussion.
Data extraction
Data were extracted independently using a standardized extraction form by two reviewers (HZ and JL)concerning patient characteristics(age, gender, BMI, etc.), study characteristics (interventions, control arms, length of intervention, length of follow-up and so on), type of blood pressure monitoring (office, home, ambulatory), co-intervention and outcome(SBP, DBP, cardiovascular events, etc.). If data were missing from published reports, we will contact the authors of the included trials for further information. Disagreements will be resolved by team discussion. FRL will review the data to ensure no input data errors.
Risk of bias assessment
Two reviewers will assess the risk of bias independently using the Cochrane of risk of bias tool. The following items will be assessed (www.cochrane-handbook.org.): Random sequence generation (selection bias); Allocation concealment (selection bias); Blinding (performance bias and detection bias); Incomplete outcome data (attrition bias); Selective outcome reporting (reporting bias). The risk of bias is categorized as low/unclear/high risk of bias. Trials which meet all criteria will be judged as having a low risk of bias, trials which meet none of the criteria will be judged as having a high risk of bias, and trials with insufficient information to judge will be classified as unclear risk of bias. Disagreement between the reviewers over the risk of bias in specific studies will be resolved by discussion and consensus, with involvement of a third review author (FRL)where necessary. Disagreement between the review authors over the risk of bias in specific studies will be resolved by discussion and consensus, with involvement of a third review author where necessary. Any discrepancies are identified and resolved through discussion with a third author where necessary. Strategy for data synthesis Weight mean differences (WMD) will be calculated for the overall mean change from baseline of both systolic and diastolic blood pressure (using office or ambulatory blood pressure measurements) for experimental and control groups. When proportion of responders (participants who reported a BP lower than 140/90mmHg after treatment) was reported, we will calculate the relative risk (RR), using control group as a reference. We will assess heterogeneity using the I 2 statistics, an I 2 >25% will be considered as existing heterogeneity among studies. In that case, we will firstly use meta regression to find out the Fixed effect model will be used when there is no evidence of heterogeneity. We will examine the potential for publication bias by using a funnel plot. If the data is not appropriate to perform a meta-analysis, we will just do a narrative synthesis.
Analyses will be performed with Stata 12.0. If required data were not reported, we will request data from corresponding author.
Analysis of subgroups or subsets
Sensitivity analysis
We will conduct sensitivity analysis to assess the effects of individual studies on the combined estimates and determine whether certain studies dominate the pooled event (particularly, if these studies were at high risk of bias). If certain studies have borderline eligibility status for any reason, analysis will be conducted with and without such studies. DiscussionMany existing systematic reviews [27 28 ] focus on the effect of single lifestyle modification on blood pressure. Although single lifestyle modification has been shown to lower elevated blood pressure, it is currently not known whether their combined use produces an additive antihypertensive effect. Of the various lifestyle interventions, physical activity and dietary intervention have been shown to diminish the blood pressure and reduce CVD events, which have emerged as the 2 most effective and physiologically desirable approaches. That is why we defined that the comprehensivemultiple lifestyle changes should at least including physical activity and dietary intervention. There is no systematic review have attempted to investigate the effectiveness of comprehensivemultiple lifestyle changes simultaneously. The aim of this systematic review is to synthesize available evidence of effectiveness of comprehensivemultiple lifestyle intervention in the treatment of prehypertension and hypertension. The systematic review also intends to help clinician to make decision on the clinical applicability of the comprehensivemultiple lifestyle modification; at the same time, the results of this review will increase understanding of comprehensivemultiple lifestyle change for patients with prehypertension and hypertension; encourage and motivate the patients with prehypertension or hypertension to adopt and maintain comprehensivemultiple lifestyle changes in their daily home life so as to improve hypertension outcomes. However, we will select the trials which implemented the comprehensivemultiple lifestyle intervention for at least 4 weeks. The comprehensivemultiple lifestyle intervention has to sustain for a time to achieve the effect to lower the blood pressure. And the trials employ lifestyle modification usually intervene for more than four weeks[21 29 30] . The reason why we exclude the trials utilizing counseling or monitoring is that both of them had been reported to achieve antihypertensive effect [31] [32] [33] . No matter counseling or monitoring, lots of manpower, material resources and financial resources have to be invested. Moreover, we exclude such trials so as to investigate the genuine effect of the comprehensivemultiple lifestyle The publishing of this protocol, along with its registration with PROSPERO[34] provides transparency and accountability for the systematic review. It will also serve as a reference document to readers of the final systematic review publication, facilitating critical appraisal of its conduct in relation to the original protocolized design. This systematic review will provide a general view and evidence of effect of multiple lifestyle change on blood pressure. The informations of this systematic review will also provide clinicians useful implication to guide their patient care. The finding of the systematic review will be disseminated through publication in a peer reviewed journal, reporting of the systematic review will follow recommendations described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
[34]statement and the Cochrane Handbook for Intervention Reviews [35] , and will be formatted according to specific journal publication guideline. The finding of the systematic review will be disseminated through publication in a peer reviewed journal, reporting of the systematic review will follow recommendations described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [35] statement and the Cochrane Handbook for Intervention Reviews[36], and will be formatted according to specific journal publication guideline.
Strengths and limitations of this study
To our knowledge, this is the first systematic review to investigate the effectiveness, efficacy and safety of multiple lifestyle changes for patients with hypertension. The results of this systematic review can provide clinicians useful clinical information to guide their patient care and increase understanding of lifestyle modification, motivate patients with hypertension to adopt and maintain multiple lifestyle changes. The limitation of this systematic review may be difficult in retrieving all the multiple lifestyle modification for patients with hypertension. We will cooperated with experienced medical librarian to design search strategy, in order to make sure a broad search. To our knowledge, this is the first systematic review to investigate the effectiveness, efficacy and safety of comprehensive lifestyle changes for patients with hypertension.
The results of this systematic review can provide clinicians useful clinical information to guide their patient care and increase understanding of lifestyle modification, motivate patients with hypertension to adopt and maintain comprehensive lifestyle changes.
The limitation of this systematic review may be difficult in retrieving all the comprehensive lifestyle modification for patients with hypertension. We will cooperated with experienced medical librarian to design search strategy, in order to make sure a broad search. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
